What type of study is this?

October 2, 2025Open Access

Bone Marrow Tumor Burden as a Predictor of Time to Progression in Asymptomatic Waldenstrom Macroglobulinemia: Evidence from a 20- year Follow-up Italian Cohort

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals high tumor burden correlates with shorter time to progression and distinct features in asymptomatic Waldenström Macroglobulinemia.

High bone marrow tumor burden in asymptomatic Waldenström Macroglobulinemia leads to significantly shorter time to progression.
Patients with higher tumor burden showed median time to progression of 64 months compared to 137 months in the low-burden group.
Factors linked to shorter time to progression included increased serum IgM levels and advanced age, emphasizing prognostic importance.
Cytogenetic abnormalities displayed trends toward significance in relation to time to progression but were not independent predictors.

Danesin et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis reveals high tumor burden correlates with shorter time to progression and distinct features in asymptomatic Waldenström Macroglobulinemia.